Data on COVID-19 in Canadians' blood show impact of vaccination campaigns, new study finds
With the EG.5 version of the virus now a variant of interest, the findings carry lessons for the next phase of the COVID-19 response
Stay updated with breaking news from David Buckeridge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With the EG.5 version of the virus now a variant of interest, the findings carry lessons for the next phase of the COVID-19 response
A surge in infections from the Omicron variant last respiratory virus season left three quarters of Canada's population with immunity against the virus that causes COVID-19.
Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.
After billions of global COVID-19 infections, millions of deaths, and countless lives upended by long-lasting health impacts, we’ve finally hit a point in this pandemic where SARS-CoV-2 isn’t the fearsome pathogen it used to be. That's thanks to how both the virus, and our immunity against it, are evolving.
With the EG.5 version of the virus now a variant of interest, the findings carry lessons for the next phase of the COVID-19 response